KLKaung Wai Yan Lwin

Kaung Wai Yan Lwin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kaung Wai Yan Lwin has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neurobiological Mechanisms and Management of Long-COVID Insomnia: A Global Systematic Review and Meta-Analysis

    by H. Aung, Z. Htun, S. Yati, K. Lwin

    Background: Many people experience insomnia as a debilitating symptom of Long-COVID even though this is one of the more prevalent clinical syndromes. Nearly 50% of Long-COVID survivors have insomnia, creating a major obstacle for functional recovery due to the lack of clear neurobiological explanations for insomnia's clinical features, and fragmented evidence for specific interventions. As a result, this meta-analysis determined the prevalence of Long-COVID Insomnia, along with the multi-systemic pathophysiologic mechanisms responsible for Long-COVID Insomnia and determined the most effective therapeutic approaches available through research evidence. Methods: Following PRISMA 2020 guidelines, we conducted a search across PubMed, Scopus, and Web of Science (2020-2025). We synthesized 53 high-quality studies (1,245 initial records) using random effects meta-analysis in R Studio. We assessed pooled prevalence, neurobiological correlates (IL-6, autonomic markers) and SMDs for intervention effects. Results: The finding indicates a significantly larger pool for insomnia is 41.5% (95% CI: between 37 and 45%). Most frequently, individuals who are female or older are at the greatest risk; therefore, we can conclude that age (OR=2.30) and sex (OR=1.76) predict risk. Based on mapping a pathophysiological signature of insomnia, 58% of individuals exhibited a neuroimmune signature of elevated IL-6, coupled with significant autonomic stability issues (r = 0.34). The strongest evidence supporting effective treatments for insomnia is derived from Cognitive Behavioral Therapy for Insomnia (CBT-I) and most of the pharmacological interventions are inferior (melatonin SMD = -0.8). Conclusion: The insomnia associated with Long-COVID represents a major public health concern caused by a complicated interaction between autonomic dysfunction and neuroinflammation. This study established cognitive-behavioral therapy and melatonin as the preferred first-line treatments for restoring sleep quality in individuals with post-viral illness; therefore, inclusion of both therapies into standard Long-COVID care is crucial to prevent long-term cognitive impairment and improve functional status.

  • Open Access

    Can Artificial Intelligence Support Healthcare Workers Managing Low-Literacy Patients in Resource-Limited Settings?

    by H. Aung, K. Lwin

    Artificial intelligence (AI) is rapidly transforming healthcare around the world with its greatest potential in low- and middle-income countries (LMICs), which face workforce shortages, long travel distances, and limited diagnostic capability. AI is an equalizing agent in resource-limited environments, reinforcing the obligation for safe and responsible use for both patients and healthcare workers as highlighted in this perspective. For instance, patients from rural areas can use AI-enabled medication checkers, to identify possible drug interactions, explain side effects, and provide reliable information about known illnesses with strong disclaimers against self-diagnosis or self-medication. For healthcare workers, AI can create efficiency in workflow, assist in the review of radiologic findings, and support task-shifting in overburdened health systems. This perspective also emphasizes the importance of AI literacy, ethical guidelines, and free continuing professional education (CME) offered by governments and policymakers to support equitable and context appropriate use. Thus, AI can provide a useful, responsible, demonstrably helpful force multiplier, augmenting healthcare capacity, patient safety, and access to quality care in low- and middle-income countries while giving providers helpful advantages in systems where they face overwhelming constraints of time and expertise.

  • Open Access

    Can Artificial Intelligence Support Healthcare Workers Managing Low-Literacy Patients in Resource-Limited Settings?

    by Htet Lin Aung, Kaung Wai Yan Lwin

    Artificial intelligence (AI) is rapidly transforming healthcare around the world with its greatest potential in low- and middle-income countries (LMICs), which face workforce shortages, long travel distances, and limited diagnostic capability. AI is an equalizing agent in resource-limited environments, reinforcing the obligation for safe and responsible use for both patients and healthcare workers as highlighted in this perspective. For instance, patients from rural areas can use AI-enabled medication checkers, to identify possible drug interactions, explain side effects, and provide reliable information about known illnesses—with strong disclaimers against self-diagnosis or self-medication. For healthcare workers, AI can create efficiency in workflow, assist in the review of radiologic findings, and support task-shifting in overburdened health systems. This perspective also emphasizes the importance of AI literacy, ethical guidelines, and free continuing professional education (CME) offered by governments and policymakers to support equitable and context appropriate use. Thus, AI can provide a useful, responsible, demonstrably helpful force multiplier, augmenting healthcare capacity, patient safety, and access to quality care in low- and middle-income countries while giving providers helpful advantages in systems where they face overwhelming constraints of time and expertise.